glaxosmithkline plc

Prestige Brands Holdings Inc. will pay British drugmaker GlaxoSmithKline PLC $660 million cash for a group of over-the-counter pharmaceutical brands including Beano and Tagamet, its largest acquisition ever.

Pharmaceutical company GlaxoSmithKline PLC said Wednesday it has received European approval for Duodart, a two-in-one drug for the treatment of the symptoms of an enlarged prostate.

UPGRADES Jefferies & Co upgrades Rosetta Stone (NYSE: RST) from Hold to Buy.

Price target raised from $24 to $29. Goldman Sachs upgrades two pharma's from Sell to Neutral:

• AstraZeneca plc (NYSE: AZN); and
• GlaxoSmithKline plc (NYSE: GSK). Click Here for more color.

Deutsche Bank upgrades China Unicom (NYSE: CHU) and China Telecom (NYSE: CHA) from Hold to Buy.

GlaxoSmithKline Plc's experimental AIDS drug reduced the virus as much as 500-fold without the signs of resistance linked to treatments from Merck & Co. and Gilead Sciences Inc., a study showed.

Epix, a struggling biotechnology firm working with British drug maker GlaxoSmithKline PLC to develop an Alzheimer's disease drug, says it is winding down its operations and selling off assets to pay off creditors.

Human Genome Sciences, Inc. (NASDAQ: HGSI) 240% HIGHER; HGSI and GlaxoSmithKline PLC (NYSE: GSK) announced that BENLYSTA met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus. Click here for the full report.

YRC Worldwide Inc.

Drugmaker GlaxoSmithKline PLC said Tuesday a study shows its human papillomavirus vaccine Cervarix was effective against the types of HPV that are most likely to cause cervical cancer, but also fought other strains of the disease.

The U.S. Food and Drug Administration has rejected GlaxoSmithKline PLC's application to approve an experimental drug for nausea and vomiting.

GlaxoSmithKline PLC signed a potential $1 billion deal with U.S. biotech company Concert Pharmaceuticals on Tuesday to access deuterium-containing medicines, a deal that will beef up its pipeline of early stage drugs.